| Length (Minutes) |
Topic |
| 35 |
Advocating for the Underserved of California: An Undeveloped Skill in Healthcare |
| |
Speaker: Noah Marco, MD, CMD |
| |
Learning Objectives: |
| |
1. Describe the value of advocacy for the underserved of California. |
| |
2. Discuss the keys to effective messaging with media and politicians. |
| |
3. Discuss the rewards of getting involved in advocacy efforts. |
| |
|
| 70 |
The Critical Role of Geriatric Medicine and LTC: Addressing the Paradoxical Challenges in our Current Healthcare System |
| |
Speaker: Kourosh A.P. Moshiri, MD, EMHA, FACP, AGSF, CMD, HMDC, FACCWS |
| |
Learning Objectives: |
| |
1. Identify the paradox of rising healthcare costs coupled with the need for improved patient outcomes, especially in the context of an aging population. |
| |
2. Discuss the demographic shift towards an older population and the subsequent strain on healthcare resources and infrastructure. |
| |
3. Analyze the fragmentation of care and its implications for patient continuity, quality, and overall system efficiency. |
| |
4. Review the four components of the Quadruple Aim and illustrate how the core concepts of geriatric medicine and long-term care (LTC) can align with and support these goals to create an effective, coordinated, multidisciplinary, age-friendly, patient-centered, and cost-effective healthcare system. |
| |
|
| 80 |
New Drugs: A 2024 Update |
| |
Speaker: Aida Oganesyan, PharmD, APh, BCGP |
| |
Learning Objectives: |
| |
1. Identify trade and generic names of newly approved drugs in 2023-2024. |
| |
2. Describe the mechanism of action for three newly approved drugs and their black box warnings. |
| |
3. Differentiate newly approved drug agents that are appropriate for use in geriatrics. |
| |
|
| 60 |
Transinstitutionalization, SMI, Overlap with Dementia |
| |
Speakers: George Woods, MD, LFAPA, Glen Xiong, MD, CMD, and Patricia Blum, PhD, CPRP |
| |
Learning Objectives: |
| |
1. Examine the movement of people with behavioral health disability across institutions |
| |
2. Define diagnostic criteria for bipolar, schizophrenia, psychosis NOS, and dementia related behavioral disturbance (How/What?) |
| |
3. Examine benefits and limitations of current treatment for a psychotic disorders |
| |
4. Discuss utility of antipsychotics for use in aggression |
| |
|
| 55 |
Psychiatric Manifestations of Medical Disorders |
| |
Speakers: George Woods, MD, LFAPA and Glen Xiong, MD, CMD |
| |
Learning Objectives: |
| |
1. Recognize potential medical conditions causing psychiatric symptoms. |
| |
2. Assess treatment options in psychiatric manifestations of medical disorders. |
| |
3. Use cognitive screens in patients who exhibit psychiatric symptoms, yet also have medical disorders. |
| |
|
| 45 |
Surrogate Decision Making and POLST: A Practical and Ethical Framework for Facilities |
| |
Speaker: Jennifer Moore Ballentine, MA |
| |
Learning Objectives: |
| |
1. Distinguish roles and authorities of healthcare agents, surrogates, and long-term care patient representatives in relation to POLST |
| |
2. Assess strengths and weaknesses among the various surrogate roles |
| |
3. Identify ethical conflicts in decision making |
| |
4. Apply an ethical framework for resolving conflicts |
| |
|
| 20 |
Diabetes: A Clinical Update |
| |
Speaker: Mai K. Nguyen, PharmD, APh, BCPP |
| |
Learning Objectives: |
| |
1. Understand the challenges of diabetes management in older adults |
| |
2. Recognize transitions of diabetes care to long-term care facility |
| |
3. Know glycemic goals for residents in the long-term care setting |
| |
4. Recognize signs of hyperglycemia and hypoglycemia |
| |
5. Understand simplified treatment regimens are preferred and better tolerated in long-term care settings
|
| |
6. Know common medication management used in the long-term care setting |
| |
|
| 65 |
Congestive Heart Failure: A 2024 Update |
| |
Speaker: Meenakshi Patel, MD, FACP, MMM, CMD |
| |
Learning Objectives: |
| |
1. Summarize the medical guidelines for management of CHF that impact long term care. |
| |
2. Discuss care transitions. |
| |
3. Apply case based approach to incorporate the guidelines. |
| |
|
| 60 |
Strategies for Managing Anxiety |
| |
Speaker: Jennifer Birdsall, PhD, ABPP |
| |
Learning Objectives: |
| |
1. Review the prevalence of anxiety. |
| |
2. Define anxiety and its various symptoms and manifestations. |
| |
3. Discuss the risk factors for anxiety, with a specific emphasis on healthcare workers. |
| |
4. Teach and offer in-vivo practice of various anxiety-management techniques. |
| |
|
| 95 |
Trauma Informed Care |
| |
Speakers: Jennifer Birdsall, PhD, ABPP and Rebecca Ferrini, MD, MPH, CMD |
| |
Learning Objectives: |
| |
1. Define “Trauma” and “Trauma Informed Care”. |
| |
2. Discuss the impact and consequences of past traumatic experiences for individuals in post-acute and long-term care facilities. |
| |
3. Review trauma-informed principles and practices and how to apply them. |
| |
4. Present case studies of trauma-informed care in practice. |
| |
|
| 45 |
Managing with Mental Health in Mind: Key Strategies for Organizations and Managers to Support Employee Well-Being |
| |
Speaker: Jennifer Birdsall, PhD, ABPP |
| |
Learning Objectives: |
| |
1. Review the state of workplace mental health |
| |
2. Discuss specific mental health risk factors for healthcare employees |
| |
3. Identify actions organizations can take to support workplace mental health |
| |
4. Discuss best in class mental health benefits organizations can consider in their employee wellness strategy |
| |
|
| 55 |
Introduction to Expert Consultation & Testimony |
| |
Moderator: Karl Steinberg, MD, CMD, HMDC, HEC-C; Legal Team: Lesley Ann Clement, Esq., and and Rick Canvel, Esq. |
| |
Learning Objectives: |
| |
1. Recognize the importance of expert testimony in elder abuse and medical malpractice litigation. |
| |
2. Evaluate your own qualifications as a potential consulting or testifying expert. |
| |
3. Compose your own review of documentation to ascertain areas of improvement. |
